Stephen Salloway

Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease

Randall J. Bateman, Chengjie Xiong, Tammie L.S. Benzinger et al. · New England Journal of Medicine · 2012 · 3.8K citations · Full text

Life Sciences, Neurology, Neuroscience +16

Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria

Bruno Dubois, Howard Feldman, Claudia Jacova et al. · The Lancet Neurology · 2014 · 3.3K citations · Full text

Medicine, Geriatric Medicine, Neurology +12

The antibody aducanumab reduces Aβ plaques in Alzheimer’s disease

Jeff Sevigny, Ping Chiao, Thierry Bussière et al. · Nature · 2016 · 3.1K citations

Life Sciences, Neurology, Neuroscience +14

Donanemab in Early Symptomatic Alzheimer Disease

John R. Sims, Jennifer A. Zimmer, Cynthia Evans et al. · JAMA · 2023 · 2.6K citations · Full text

Medicine, Neurology, Neuroscience +17

Two Phase 3 Trials of Bapineuzumab in Mild-to-Moderate Alzheimer's Disease

Stephen Salloway, Reisa A. Sperling, Nick C. Fox et al. · New England Journal of Medicine · 2014 · 2K citations · Full text

Medicine, Neurology, Pharmacology +17